INDOCO REMEDIES LTD.
Smart Quotes
Trade Value (Rs. in Lacs) | 0.00 |
Dividend Yield(%) | 0.67 |
TTM EPS (Rs.) | 11.33 |
P/E Ratio | 29.77 |
Book Value (Rs.) | 117.89 |
Face Value (Rs.) | 2 |
MCap (Rs. in Mn) | 31102.28 |
Price/Earning (TTM) | 16.69 |
Price/Sales (TTM) | 1.77 |
Price/Book (MRQ) | 2.86 |
PAT Margin (%) | 8.48 |
ROCE (%) | 17.42 |
Management Info :
Suresh G Kare - Chairman Aditi Panandikar - Managing DirectorRegistered Office :
Address :
Indoco House,166 C S T Road,Kalina , Santacruz (East),
Mumbai,
Maharashtra-400098
Phone : 022-62871000 / 68791250
Email : compliance.officer@indoco.com
Website : www.indoco.com
QTR Dec 23 | ANNUAL 23 | |
---|---|---|
Net Profit | 200.1 | 1413.6 |
Gross Profit | 270.2 | 1915.9 |
Operating Profit | 682.2 | 2872.2 |
Net Sales | 4490.5 | 16666.9 |
Ajanta Pharma (BSE)  2377.00 (6.44%) | M.Cap ( in Cr) 29930.39 |
Alkem Laboratories (BSE)  4899.45 (2.36%) | M.Cap ( in Cr) 58580.27 |
Astrazeneca Pharma I (BSE)  5424.45 (1.70%) | M.Cap ( in Cr) 13561.13 |
Dr. Reddy's Lab (BSE)  6349.95 (0.98%) | M.Cap ( in Cr) 105928.76 |
Torrent Pharma (BSE)  2732.60 (2.20%) | M.Cap ( in Cr) 92483.60 |
|
PROMOTERS | 58.72 % |
|
NON-INSTITUTION | 19.95 % |
|
MUTUAL FUNDS/UTI | 17.91 % |
|
FI/BANKS/INSURANCE | 0.29 % |
|
GOVERNMENT | 0 % |
|
FII | 0 % |
Scheme Name | Hold(%) |
---|---|
Quant Healthcare Fund-R... | 3.98 |
DSP Healthcare Fund-Reg... | 2.36 |
Sundaram LT Micro Cap T... | 1.88 |
Sundaram LT Micro Cap T... | 1.66 |
Sundaram LT Micro Cap T... | 1.53 |
Sundaram LT Micro Cap T... | 1.52 |